La Monica N, Racaniello V R
Department of Microbiology, Columbia University College of Physicians and Surgeons, New York, New York 10032.
J Virol. 1989 May;63(5):2357-60. doi: 10.1128/JVI.63.5.2357-2360.1989.
A base change from C to U at position 472 of the 5' noncoding region of the poliovirus genome is known to be a major determinant of attenuation in the P3/Sabin vaccine strain. To determine the biochemical basis for the attenuated phenotype imparted by this mutation, a cell line in which replication of neurovirulent and attenuated viruses could be distinguished was identified. A pair of P3/Sabin-P2/Lansing viral recombinants that differ only at position 472 was used; the viruses replicated equally well in HeLa cells, but the virus with a U at base 472 was attenuated in mice. In the human neuroblastoma cell line SH-SY5Y, recombinants with a U at base 472 replicated to approximately 10-fold-lower titers than did neurovirulent viruses with a C at this position. Analysis of viral RNA and protein synthesis indicated that translation of the attenuated viral RNA was specifically reduced in SH-SY5Y cells.
已知脊髓灰质炎病毒基因组5'非编码区第472位的碱基从C变为U是P3/Sabin疫苗株减毒的主要决定因素。为了确定这种突变赋予减毒表型的生化基础,鉴定了一种能够区分神经毒力病毒和减毒病毒复制的细胞系。使用了一对仅在第472位不同的P3/Sabin-P2/Lansing病毒重组体;这些病毒在HeLa细胞中复制情况相同,但第472位碱基为U的病毒在小鼠中减毒。在人神经母细胞瘤细胞系SH-SY5Y中,第472位碱基为U的重组体的复制滴度比该位置碱基为C的神经毒力病毒低约10倍。对病毒RNA和蛋白质合成的分析表明,减毒病毒RNA的翻译在SH-SY5Y细胞中特异性降低。